AtriCure Reports Second Quarter 2022 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- Wall St slips as higher Treasury yields weigh on sentiment
- Oil pares losses as market weighs Saudi supply concerns, Middle East tensions
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
AtriCure (ATRC) Misses Q2 EPS by 3c
August 2, 2022 4:01 PM EDTAtriCure (NASDAQ: ATRC) reported Q2 EPS of ($0.32), $0.03 worse than the analyst estimate of ($0.29). Revenue for the quarter came in at $84.5 million versus the consensus estimate of $79.67 million.
GUIDANCE:
AtriCure sees FY2022 EPS of ($1.07)-($1.12), versus the consensus of ($1.10). AtriCure sees... More
